Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with ...

Central vision can fade slowly with age-related macular degeneration. Faces blur. Words smear on a page. A dark spot can sit ...

Electronic retinal implants such as the PRIMA system bypass damaged cells to restore partial central vision, bringing ...

Age-related macular degeneration (AMD) once meant a slow, irreversible loss of vision, and many people still believe that's true. But the AMD of today isn't the AMD of ...

Companies across the globe are diligently working toward developing novel Dry Age Macular Degeneration treatment therapies ...

OCU410 controlled lesion growth 46% better than placebo in dAMD-related GA.

Medically reviewed by Christine L. Larsen, MD Key Takeaways Macular degeneration is a common eye disease, affecting more than 19 million people in the United States alone.The condition can reduce a ...

Ocugen has announced positive preliminary 12-month data from its phase 2 ArMaDa trial evaluating OCU410 (AAV5-RORA) for the ...

NEW YORK, Oct. 24 (UPI) --Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the development and progression of age-related macular ...

Ask a clinical question and tap into Healio AI's knowledge base. Assessment of visual function by testing for visual acuity, dark adaptation, contrast sensitivity and evaluation of retinal sensitivity ...

Subretinal transplantation of retinal pigment epithelium derived from human embryonic stem cells (hESCs) appears to be a well-tolerated means of treating age-related macular degeneration and Stargardt ...

Ask a clinical question and tap into Healio AI's knowledge base. Patients with age-related macular degeneration (AMD) vary in their visual symptoms and disease progression based on the different forms ...